Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1510

1.

Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP).

Howells L, Chalmers JR, Gran S, Ahmed A, Apfelbacher C, Burton T, Howie L, Lawton S, Ridd M, Rogers NK, Sears AV, Spuls P, von Kobyletzki L, Thomas KS.

Br J Dermatol. 2019 Dec 3. doi: 10.1111/bjd.18780. [Epub ahead of print]

PMID:
31794074
2.

Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure.

Sharman JE, O'Brien E, Alpert B, Schutte AE, Delles C, Hecht Olsen M, Asmar R, Atkins N, Barbosa E, Calhoun D, Campbell NRC, Chalmers J, Benjamin I, Jennings G, Laurent S, Boutouyrie P, Lopez-Jaramillo P, McManus RJ, Mihailidou AS, Ordunez P, Padwal R, Palatini P, Parati G, Poulter N, Rakotz MK, Rosendorff C, Saladini F, Scuteri A, Sebba Barroso W, Cho MC, Sung KC, Townsend RR, Wang JG, Willum Hansen T, Wozniak G, Stergiou G; Lancet Commission on Hypertension Group.

J Hypertens. 2020 Jan;38(1):21-29. doi: 10.1097/HJH.0000000000002246.

PMID:
31790375
3.

Could We Make Better Use of Raised Blood Pressure Readings in the Emergency Department?

Chalmers J.

Hypertension. 2019 Dec 2:HYPERTENSIONAHA11914072. doi: 10.1161/HYPERTENSIONAHA.119.14072. [Epub ahead of print] No abstract available.

PMID:
31786981
4.

Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis.

Finch S, Laska IF, Abo-Leyah H, Fardon TC, Chalmers JD.

Chest. 2019 Nov 12. pii: S0012-3692(19)34198-4. doi: 10.1016/j.chest.2019.10.030. [Epub ahead of print]

PMID:
31730832
5.

Observational analyses from ADVANCE and ADVANCE-ON.

Chalmers J, Woodward M.

Diabetes Obes Metab. 2019 Nov 14. doi: 10.1111/dom.13894. [Epub ahead of print]

PMID:
31729126
6.

Sex differences in treatment and outcome after stroke: Pooled analysis including 19,000 participants.

Carcel C, Wang X, Sandset EC, Delcourt C, Arima H, Lindley R, Hackett ML, Lavados P, Robinson TG, Muñoz Venturelli P, Olavarría VV, Brunser A, Berge E, Chalmers J, Woodward M, Anderson CS.

Neurology. 2019 Nov 12. pii: 10.1212/WNL.0000000000008615. doi: 10.1212/WNL.0000000000008615. [Epub ahead of print]

PMID:
31719135
7.

Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration.

Shteinberg M, Crossley B, Lavie T, Nadler S, Boyd J, Ringshausen FC, Aksamit T, Chalmers JD, Goeminne P.

ERJ Open Res. 2019 Oct 30;5(4). pii: 00113-2019. doi: 10.1183/23120541.00113-2019. eCollection 2019 Oct.

8.

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.

Langham S, Lewis J, Pooley N, Embleton N, Langham J, Han MK, Chalmers JD.

Respir Res. 2019 Nov 4;20(1):242. doi: 10.1186/s12931-019-1213-9. Review.

9.

The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in England.

Campling J, Jones D, Chalmers JD, Jiang Q, Vyse A, Madhava H, Ellsbury G, Slack M.

Pneumonia (Nathan). 2019 Oct 11;11:4. doi: 10.1186/s41479-019-0063-z. eCollection 2019.

10.

Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.

Oriano M, Terranova L, Sotgiu G, Saderi L, Bellofiore A, Retucci M, Marotta C, Gramegna A, Miglietta D, Carnini C, Marchisio P, Chalmers JD, Aliberti S, Blasi F.

Pulm Pharmacol Ther. 2019 Dec;59:101856. doi: 10.1016/j.pupt.2019.101856. Epub 2019 Oct 15.

PMID:
31626976
11.

The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

Lee AK, Woodward M, Wang D, Ohkuma T, Warren B, Sharrett AR, Williams B, Marre M, Hamet P, Harrap S, McEvoy JW, Chalmers J, Selvin E.

J Clin Endocrinol Metab. 2019 Oct 7. pii: dgz045. doi: 10.1210/clinem/dgz045. [Epub ahead of print]

PMID:
31588504
12.

The microbiome in bronchiectasis: Cutting a lung story short.

Smith AH, Chalmers JD.

Respirology. 2019 Oct 6. doi: 10.1111/resp.13697. [Epub ahead of print] No abstract available.

13.

Cystic fibrosis lung disease and bronchiectasis.

Chalmers JD.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30335-2. doi: 10.1016/S2213-2600(19)30335-2. [Epub ahead of print] No abstract available.

PMID:
31570316
14.

Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?

Spinou A, Chalmers JD.

Eur Respir J. 2019 Sep 28;54(3). pii: 1901610. doi: 10.1183/13993003.01610-2019. Print 2019 Sep. No abstract available.

PMID:
31563873
15.

Inflation of 430-parsec bipolar radio bubbles in the Galactic Centre by an energetic event.

Heywood I, Camilo F, Cotton WD, Yusef-Zadeh F, Abbott TD, Adam RM, Aldera MA, Bauermeister EF, Booth RS, Botha AG, Botha DH, Brederode LRS, Brits ZB, Buchner SJ, Burger JP, Chalmers JM, Cheetham T, de Villiers D, Dikgale-Mahlakoana MA, du Toit LJ, Esterhuyse SWP, Fanaroff BL, Foley AR, Fourie DJ, Gamatham RRG, Goedhart S, Gounden S, Hlakola MJ, Hoek CJ, Hokwana A, Horn DM, Horrell JMG, Hugo B, Isaacson AR, Jonas JL, Jordaan JDBL, Joubert AF, Józsa GIG, Julie RPM, Kapp FB, Kenyon JS, Kotzé PPA, Kriel H, Kusel TW, Lehmensiek R, Liebenberg D, Loots A, Lord RT, Lunsky BM, Macfarlane PS, Magnus LG, Magozore CM, Mahgoub O, Main JPL, Malan JA, Malgas RD, Manley JR, Maree MDJ, Merry B, Millenaar R, Mnyandu N, Moeng IPT, Monama TE, Mphego MC, New WS, Ngcebetsha B, Oozeer N, Otto AJ, Passmoor SS, Patel AA, Peens-Hough A, Perkins SJ, Ratcliffe SM, Renil R, Rust A, Salie S, Schwardt LC, Serylak M, Siebrits R, Sirothia SK, Smirnov OM, Sofeya L, Swart PS, Tasse C, Taylor DT, Theron IP, Thorat K, Tiplady AJ, Tshongweni S, van Balla TJ, van der Byl A, van der Merwe C, van Dyk CL, Van Rooyen R, Van Tonder V, Van Wyk R, Wallace BH, Welz MG, Williams LP.

Nature. 2019 Sep;573(7773):235-237. doi: 10.1038/s41586-019-1532-5. Epub 2019 Sep 11.

PMID:
31511683
16.

Intensive glucose-lowering and the risk of vascular events and premature death in patients with decreased kidney function: The ADVANCE trial.

Ohkuma T, Zoungas S, Jun M, Lisheng L, Mancia G, Marre M, Rodgers A, Williams B, Woodward M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Obes Metab. 2019 Sep 4. doi: 10.1111/dom.13878. [Epub ahead of print]

PMID:
31486188
17.

The microbiome in bronchiectasis.

Richardson H, Dicker AJ, Barclay H, Chalmers JD.

Eur Respir Rev. 2019 Sep 4;28(153). pii: 190048. doi: 10.1183/16000617.0048-2019. Print 2019 Sep 30.

18.

Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes.

McKeigue PM, Spiliopoulou A, McGurnaghan S, Colombo M, Blackbourn L, McDonald TJ, Onengut-Gomuscu S, Rich SS, A Palmer CN, McKnight JA, J Strachan MW, Patrick AW, Chalmers J, Lindsay RS, Petrie JR, Thekkepat S, Collier A, MacRury S, Colhoun HM.

BMC Med. 2019 Aug 23;17(1):165. doi: 10.1186/s12916-019-1392-8.

19.

Protocol for an outcome assessor-blinded pilot randomised controlled trial of an ion-exchange water softener for the prevention of atopic eczema in neonates, with an embedded mechanistic study: the Softened Water for Eczema Prevention (SOFTER) trial.

Jabbar-Lopez ZK, Gurung N, Greenblatt D, Briley A, Chalmers JR, Thomas KS, Frost T, Kezic S, Common JEA, Kong HH, Segre JA, Danby S, Cork MJ, Peacock JL, Flohr C.

BMJ Open. 2019 Aug 20;9(8):e027168. doi: 10.1136/bmjopen-2018-027168.

20.

Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).

Loebinger MR, Polverino E, Blasi F, Elborn SJ, Chalmers JD, Tiddens HA, Goossens H, Tunney M, Zhou W, Angyalosi G, Hill AT, Haworth CS; iBEST-1 Trial Team.

Pulm Pharmacol Ther. 2019 Oct;58:101834. doi: 10.1016/j.pupt.2019.101834. Epub 2019 Aug 18.

PMID:
31433997
21.

Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study.

Carcel C, Neal B, Oparil S, Rogers K, Narkiewicz K, Wang JG, Schiffrin EL, Poulter N, Azizi M, Chalmers J.

J Hypertens. 2019 Nov;37(11):2216-2224. doi: 10.1097/HJH.0000000000002184.

PMID:
31415307
22.

Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis.

Chalmers JD, Boersma W, Lonergan M, Jayaram L, Crichton ML, Karalus N, Taylor SL, Martin ML, Burr LD, Wong C, Altenburg J.

Lancet Respir Med. 2019 Oct;7(10):845-854. doi: 10.1016/S2213-2600(19)30191-2. Epub 2019 Aug 9.

PMID:
31405828
23.

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.

Laska IF, Crichton ML, Shoemark A, Chalmers JD.

Lancet Respir Med. 2019 Oct;7(10):855-869. doi: 10.1016/S2213-2600(19)30185-7. Epub 2019 Aug 9.

PMID:
31405826
24.

Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.

Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, Trivedi S, Rajagopala S, D'Souza G, Padmanabhan A, Baburao A, Mahesh PA, Ghewade B, Nair G, Jindal A, Jayadevappa GDH, Sawhney H, Sarmah KR, Saha K, Anantharaj S, Khanna A, Gami S, Shah A, Shah A, Dutt N, Garg H, Vyas S, Venugopal K, Prasad R, Aleemuddin NM, Karmakar S, Singh V, Jindal SK, Sharma S, Prajapat D, Chandrashekaria S, McDonnell MJ, Mishra A, Rutherford R, Ramanathan RP, Goeminne PC, Vasudev P, Dimakou K, Crichton ML, Jayaraj BS, Kungwani R, Das A, Sawhney M, Polverino E, Torres A, Gulecha NS, Shteinberg M, De Soyza A, Mangala A, Shah P, Chauhan NK, Jajodia N, Singhal A, Batra S, Hasan A, Limaye S, Salvi S, Aliberti S, Chalmers JD.

Lancet Glob Health. 2019 Sep;7(9):e1269-e1279. doi: 10.1016/S2214-109X(19)30327-4. Erratum in: Lancet Glob Health. 2019 Dec;7(12):e1621.

25.

Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.

Moullaali TJ, Wang X, Martin RH, Shipes VB, Robinson TG, Chalmers J, Suarez JI, Qureshi AI, Palesch YY, Anderson CS.

Lancet Neurol. 2019 Sep;18(9):857-864. doi: 10.1016/S1474-4422(19)30196-6.

PMID:
31397290
26.

Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?

Laska IF, Chalmers JD.

Eur Respir J. 2019 Jul 18;54(1). pii: 1901213. doi: 10.1183/13993003.01213-2019. Print 2019 Jul. No abstract available.

PMID:
31320480
27.

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.

Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, Hadjadj S, Hamet P, Harrap S, Mancia G, Marre M, Williams B, Chalmers J, Woodward M, Perkovic V; ADVANCE Collaborative Group.

Diabetologia. 2019 Nov;62(11):1988-1997. doi: 10.1007/s00125-019-4948-4. Epub 2019 Jul 13.

28.

Same meat, different gravy: ignore the new names of mycobacteria.

Tortoli E, Brown-Elliott BA, Chalmers JD, Cirillo DM, Daley CL, Emler S, Floto RA, Garcia MJ, Hoefsloot W, Koh WJ, Lange C, Loebinger M, Maurer FP, Morimoto K, Niemann S, Richter E, Turenne CY, Vasireddy R, Vasireddy S, Wagner D, Wallace RJ Jr, Wengenack N, van Ingen J.

Eur Respir J. 2019 Jul 11;54(1). pii: 1900795. doi: 10.1183/13993003.00795-2019. Print 2019 Jul. No abstract available.

PMID:
31296783
29.

Changes in plasma lipids predict pravastatin efficacy in secondary prevention.

Jayawardana KS, Mundra PA, Giles C, Barlow CK, Nestel PJ, Barnes EH, Kirby A, Thompson P, Sullivan DR, Alshehry ZH, Mellett NA, Huynh K, McConville MJ, Zoungas S, Hillis GS, Chalmers J, Woodward M, Marschner IC, Wong G, Kingwell BA, Simes J, Tonkin AM, Meikle PJ; LIPID Study Investigators.

JCI Insight. 2019 Jul 11;4(13). pii: 128438. doi: 10.1172/jci.insight.128438. eCollection 2019 Jul 11.

30.

Antimicrobial peptides, disease severity and exacerbations in bronchiectasis.

Sibila O, Perea L, Cantó E, Shoemark A, Cassidy D, Smith AH, Suarez-Cuartin G, Rodrigo-Troyano A, Keir HR, Oriano M, Ong S, Vidal S, Blasi F, Aliberti S, Chalmers JD.

Thorax. 2019 Sep;74(9):835-842. doi: 10.1136/thoraxjnl-2018-212895. Epub 2019 Jul 5.

PMID:
31278172
31.

Pregnancy Zone Protein Is Associated with Airway Infection, Neutrophil Extracellular Trap Formation, and Disease Severity in Bronchiectasis.

Finch S, Shoemark A, Dicker AJ, Keir HR, Smith A, Ong S, Tan B, Choi JY, Fardon TC, Cassidy D, Huang JTJ, Chalmers JD.

Am J Respir Crit Care Med. 2019 Oct 15;200(8):992-1001. doi: 10.1164/rccm.201812-2351OC.

32.

Who will benefit more from low-dose alteplase in acute ischemic stroke?

Wang X, Lee KJ, Moullaali TJ, Kim BJ, Li Q, Bae HJ, Carcel C, Delcourt C, Arima H, Sato S, Robinson TG, Song L, Chen G, Yang J, Chalmers J, Anderson CS, Lindley R, Woodward M; ENCHANTED Investigators.

Int J Stroke. 2019 Jun 21:1747493019858775. doi: 10.1177/1747493019858775. [Epub ahead of print]

PMID:
31226920
33.

Response.

Chalmers JD.

Chest. 2019 Jun;155(6):1302-1303. doi: 10.1016/j.chest.2019.02.316. No abstract available.

PMID:
31174643
34.

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Ohkuma T, Jun M, Chalmers J, Cooper ME, Hamet P, Harrap S, Zoungas S, Perkovic V, Woodward M; ADVANCE Collaborative Group.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):862-872. doi: 10.2215/CJN.13391118. Epub 2019 Jun 3.

PMID:
31160317
35.

A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.

Shoemark A, Cant E, Carreto L, Smith A, Oriano M, Keir HR, Perea L, Canto E, Terranova L, Vidal S, Moffitt K, Aliberti S, Sibila O, Chalmers JD.

Eur Respir J. 2019 Jun 13;53(6). pii: 1900303. doi: 10.1183/13993003.00303-2019. Print 2019 Jun.

PMID:
31151955
36.

Determinants of Early Versus Delayed Neurological Deterioration in Intracerebral Hemorrhage.

You S, Zheng D, Delcourt C, Sato S, Cao Y, Zhang S, Yang J, Wang X, Lindley RI, Robinson T, Anderson CS, Chalmers J.

Stroke. 2019 Jun;50(6):1409-1414. doi: 10.1161/STROKEAHA.118.024403. Epub 2019 Apr 18.

PMID:
31136288
37.

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC).

Rahimi K, Canoy D, Nazarzadeh M, Salimi-Khorshidi G, Woodward M, Teo K, Davis BR, Chalmers J, Pepine CJ; Blood Pressure Lowering Treatment Trialists’ Collaboration.

BMJ Open. 2019 May 22;9(5):e028698. doi: 10.1136/bmjopen-2018-028698.

38.

Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis.

Sibila O, Laserna E, Shoemark A, Keir HR, Finch S, Rodrigo-Troyano A, Perea L, Lonergan M, Goeminne PC, Chalmers JD.

Am J Respir Crit Care Med. 2019 Jul 1;200(1):33-41. doi: 10.1164/rccm.201809-1651OC.

PMID:
31109172
39.

Rheumatoid arthritis-associated bronchiectasis - Authors' reply.

Flume PA, Chalmers JD, Olivier KN.

Lancet. 2019 May 18;393(10185):2036. doi: 10.1016/S0140-6736(19)30012-1. No abstract available.

PMID:
31106746
40.

Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage.

Wang X, Sandset EC, Moullaali TJ, Chen G, Song L, Carcel C, Delcourt C, Woodward M, Robinson T, Chalmers J, Arima H, Anderson CS; INTERACT2 Investigators.

J Hypertens. 2019 Jul;37(7):1463-1466. doi: 10.1097/HJH.0000000000002056.

PMID:
31085948
41.

TEST (Trial of Eczema allergy Screening Tests): protocol for feasibility randomised controlled trial of allergy tests in children with eczema, including economic scoping and nested qualitative study.

Ridd MJ, Edwards L, Santer M, Chalmers JR, Waddell L, Marriage D, Muller I, Roberts K, Garfield K, Coast J, Selman L, Clement C, Shaw ARG, Angier E, Blair PS, Turner NL, Taylor J, Kai J, Boyle RJ.

BMJ Open. 2019 May 9;9(5):e028428. doi: 10.1136/bmjopen-2018-028428.

42.

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort.

Chalmers J, Ban L, Leena KB, Edwards KL, Grove JL, Aithal GP, Shenoy KT.

BMJ Open. 2019 May 5;9(5):e027244. doi: 10.1136/bmjopen-2018-027244.

43.

Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial.

Chalmers JD, Crichton ML, Brady G, Finch S, Lonergan M, Fardon TC.

BMC Pulm Med. 2019 May 6;19(1):85. doi: 10.1186/s12890-019-0856-0.

44.

Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.

Selvin E, Wang D, McEvoy JW, Juraschek SP, Lazo M, Hamet P, Cooper ME, Marre M, Williams B, Harrap S, Chalmers J, Woodward M.

Diabetes Obes Metab. 2019 Aug;21(8):2017-2023. doi: 10.1111/dom.13755. Epub 2019 May 29.

PMID:
31050156
45.

Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.

VanDevanter DR, Gonda I, Dahms J, Cipolla D, Davis AM, Chalmers JD, Froehlich J.

Clin Microbiol Infect. 2019 Dec;25(12):1532-1538. doi: 10.1016/j.cmi.2019.04.017. Epub 2019 Apr 26.

PMID:
31035017
46.

Effects of Blood Pressure Lowering on Clinical Outcomes According to Baseline Blood Pressure and Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus.

Rahman F, McEvoy JW, Ohkuma T, Marre M, Hamet P, Harrap S, Mancia G, Rodgers A, Selvin E, Williams B, Muntner P, Chalmers J, Woodward M.

Hypertension. 2019 Jun;73(6):1291-1299. doi: 10.1161/HYPERTENSIONAHA.118.12414.

PMID:
31030606
47.

Bronchiectasis Guidelines-Recommendations Into Practice.

Redondo M, Chalmers JD.

Arch Bronconeumol. 2019 Jun;55(6):286-288. doi: 10.1016/j.arbres.2018.10.012. Epub 2019 Apr 10. English, Spanish. No abstract available.

48.

Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry.

Robinson TG, Bray BD, Paley L, Sprigg N, Wang X, Arima H, Bath PM, Broderick JP, Durham AC, Kim JS, Lavados PM, Lee TH, Martins S, Nguyen TH, Pandian JD, Parsons MW, Pontes-Neto OM, Ricci S, Sharma VK, Wang J, Woodward M, Rudd AG, Chalmers J, S Anderson C; ENCHANTED Investigators and the SSNAP Collaboration.

Int J Stroke. 2019 Oct;14(7):678-685. doi: 10.1177/1747493019841246. Epub 2019 Apr 8.

PMID:
30961463
49.

A Subpopulation of Monocytes in Normal Human Blood Has Significant Magnetic Susceptibility: Quantification and Potential Implications.

Kim J, Gómez-Pastora J, Weigand M, Potgieter M, A Walters N, Reátegui E, F Palmer A, Yazer M, Zborowski M, Chalmers JJ.

Cytometry A. 2019 May;95(5):478-487. doi: 10.1002/cyto.a.23755. Epub 2019 Apr 8.

PMID:
30958642
50.

New Blood Pressure Guidelines Pose Difficult Choices for Australian Physicians.

Harrap SB, Lung T, Chalmers J.

Circ Res. 2019 Mar 29;124(7):975-977. doi: 10.1161/CIRCRESAHA.118.314637. No abstract available.

PMID:
30920933

Supplemental Content

Loading ...
Support Center